Breast cancer is the most common malignancy afflicting women in the United States. Recent developments in molecular and cellular biology research have brought us closer to understanding the genetic basis of breast cancer. Yet, these new technologies have not been incorporated into the clinical use. Advancements in microarray technology hold promise of further increasing our understanding of the complexity and heterogeneity of this disease and providing new avenues for the prognostication and prediction of breast cancer outcomes. Some recent applications of microarray genomic technologies in studying breast cancer will be the focus of this review.
|Original language||English (US)|
|Number of pages||5|
|Journal||Drug Discovery Today: Therapeutic Strategies|
|State||Published - 2005|
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery